In this webinar designed for patients and caregivers, David A. Reardon, M.D., discussed current immunotherapy treatment options for patients with brain cancer, and how close we are to making these treatments available to more patients.
David A. Reardon, M.D., currently serves as Clinical Director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute and previously served as the Associate Deputy Director of the Preston Robert Tisch Brain Tumor Center at Duke University Medical Center. His work includes using innovative clinical therapies to improve cure rates in patients with brain and spinal tumors, with particular focus on immunotherapies.
This webinar is part of the Cancer Research Institute's webinar series, "Cancer Immunotherapy and You," which are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&A. This webinar was generously supported by Agenus. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.